FDA Inspection 1048864 — scPharmaceuticals Inc.

scPharmaceuticals Inc. — FEI 3013722099

The FDA completed an inspection of scPharmaceuticals Inc. on Mar 29, 2018 in Burlington, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 29, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Compliance: Devices
Location
Burlington, MA (United States)